Syros Pharmaceuticals, Inc. (SYRS) Stock Forecast
SYRS analyst forecast
as of October 21, 2026- Analyst consensus
- Hold 3.00 / 5 from 3 analysts
- Price target
- $8.75 average of analyst targets
- Upside to target
- +2,187,400.0% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $0.00
SYRS analyst ratings
3 analystsNumber of analysts at each rating.
SYRS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SYRS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SYRS beat in 9 of 12.
What analysts expect from SYRS
3 analysts cover Syros Pharmaceuticals; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $8.75, 2,187,400.0% above the latest close of $0.00. Syros Pharmaceuticals beat the EPS estimate in 9 of the last 12 quarters.
Related: SYRS income statement, SYRS key metrics, SYRS chart. See the SYRS stock overview for the latest quote and news.
SYRS forecast FAQ
What is Syros Pharmaceuticals's price target?
The average analyst price target for Syros Pharmaceuticals is $8.75, 2,187,400.0% above the latest close of $0.00.
Is Syros Pharmaceuticals a buy, hold or sell?
Of 3 analysts covering Syros Pharmaceuticals, 0 rate it a strong buy, 0 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
Does Syros Pharmaceuticals usually beat earnings estimates?
Syros Pharmaceuticals reported EPS at or above the analyst estimate in 9 of the last 12 quarters.